YEUNG, Wai-Kwok Kelvin

Professor Kelvin Yeung is a distinguished scholar in the field of orthopaedic biomaterial research, with a particular emphasis on the design of orthopaedic biomaterials, antibacterial nanomaterials, 3D bioprinting, and musculoskeletal tissue engineering. He earned his bachelor’s degree in materials science before advancing to attain both a master’s degree and a PhD in orthopaedic science from the University of Hong Kong’s Medical Faculty. Throughout his career, he has dedicated his research to critical areas such as bone-to-implant osseointegration, bone regeneration, and the development of antibacterial treatments.

Currently, Professor Yeung holds the Ng Chun-Man Professorship in Orthopaedic Bioengineering and serves as a tenured full professor, chief of the research division, and departmental research and postgraduate advisor within the Department of Orthopaedics and Traumatology at the School of Clinical Medicine, LKS Faculty of Medicine (HKUMed), The University of Hong Kong. His academic stature is further amplified by honorary appointments as the Director (HKU) of the Chinese Academy of Sciences Shenzhen-Hong Kong Joint Laboratory for Biomaterials, a Professor in the Department of Orthopaedics at Zhongshan Hospital, and as Principal Researcher in the Institute of Spinal Tumor at Fudan University. His scholarly impact is evident, with an impressive h-index of 92 according to Scopus, reflecting over 30,446 citations, while his Google Scholar metrics reveal an h-index of 102 with more than 35,664 citations and an i10-index of 300. Honourably, he has been identified as one of the Highly Cited Researchers for 2023 to 2025 (cross-field), Highly Ranked Scholar 2022 (Prior Five Years) in the field of Medicine by ScholarGPS (Global ranking: #7 in Biomaterial; #16 in Orthopaedic Surgery), Top Cited Scholar 2024, and he ranks among the Top 1% of scholars worldwide in biomaterials, as recognized by Clarivate Analytics’ Essential Science Indicators (ESI), and the World’s Top 2% Scientists in standardized citation indicators (Biomedical Engineering) since 2014. In 2026, he was positioned at #1346 globally and #440 in China in the category of materials science by Research.com.

Beyond a robust publication record, including over 330 peer-reviewed SCI journal articles and 47 filed patents in various jurisdictions. Professor Yeung co-founded NeurOssence Bio Limited with his post-doctoral fellow, effectively bridging the gap between research and clinical application. He also serves as a consultant for several publicly listed medical and biomaterials companies in Hong Kong.

Throughout his illustrious career, Professor Yeung has actively engaged in numerous local and regional competitions, garnering accolades such as the Fudan Scholar (2024), Young Scientist Award (2005), Young Engineer Award (2009), and Faculty Research Output Award (2019 and 2023). In recent years, he was also elected as Fellow of American Institute for Medical and Biological Engineering (AIMBE), Fellow of International Academy of Medical and Biological Engineering (IAMBE) and Fellow of the International Association of Advanced Materials (IAAM). As both principal investigator and co-principal investigator, he has successfully secured funding exceeding HK$105,100,000. A fervent advocate for diversity, equity, and inclusion, he has trained 3 Research Assistant Professors, 21 postdoctoral researchers, 35 PhD students, 16 Master’s students, and 4 undergraduate students, with over 50% representing female, African, or Middle-Eastern backgrounds. His contributions to the scientific community are substantiated by more than 40 awards from various local and international competitions and conferences, alongside invitations to deliver over 90 plenary lectures, keynotes, and invited talks at prestigious conferences.

In addition to his research and teaching commitments, Professor Yeung plays an active role in several local and international academic organizations. He serves as Associate Editor for the ‘Bioactive Materials Journal’ (impact factor: 23.6, ranking #2 out of 58 in materials science (biomaterials); and #3 out of 130 in engineering (biomedical), is a founding member and current President of the Chinese Association for Biomaterials (CAB). He previously acted as Secretary and Treasurer of CAB, Chair and Vice-Chair of Orthopaedic Biomaterials section of the Society for Biomaterials (SFB) USA. Furthermore, he has been appointed as the Dean of Student Affairs by the university, where he oversees initiatives aimed at enhancing student educational development.

• Scoliosis and surgical correction for spinal deformities
• Bone fracture management 
• Implant-related osteomyelitis
• Antibacterial nano-materials
• Musculoskeletal tissue engineering
• 3D bioprinting
• Orthopaedic implant design and translation research
• Orthopaedic biodegradable materials
• Surface treatments of biomaterials

Ten selected publications: Journal publications: Number of peer-reviewed SCI journal papers:341; Number of conference abstracts:340+; Number of granted/filed patents:48; Number of book chapters: 8; h-index: 102 with 35,664 total citations, i10-index 300 (Google Scholar) and 92 with 30,446 total citations (Scopus); Highly Cited Researchers 2023 to 2025 (Cross-field); Highly Ranked Scholar 2022 (Prior Five Years) in the field of Medicine by ScholarGPS (Global ranking: #7 in Biomaterial; #16 in Orthopaedic Surgery); Top Cited Scholar 2024 recognised by Scilit; Top 1% Scholars Worldwide in the field of Biomaterials by Essential Science Indicators (ESI) (2014-2025); Top 2% Scientists (Career Long and Single Year under Biomedical Engineering) (2021-2025); ranked as #1346 in the world and #440 in China under the category of materials science in 2026 (Research.com)

1. Congyang Mao^#, Wanyu Jin^#, Limeng Dou^#, Tong Guo^#, Jin Huang, Yi Wang, Xiangmei Liu*, Wei Qiao, Yiming Xiang, Yizhou Zhu, Jun Wu, Shuilin Wu*, Kelvin Wai Kwok Yeung*. Bioengineered Escherichia coli Nissle 1917 with ROS tolerance modulates gut microbiota-host metabolic axis to ameliorate type 2 diabetes. Nature Communications, Vol.17, article number: 3339, March 2026. (IF:18.1, top 7 out of 140 in the field)
2. Feihong Liu, Shasha Yao, Jia Li, Kejie Huang, Dongdong Zhang, Tak Man Wong, Ruikang Tang*, Kelvin W.K. Yeung*, Jun Wu*. Inorganic-organic Hybrid Metamaterials with Switchable High Stiffness and Elasticity. Nature Communications, Vol.16(1), pp.4423, May 2025. (IF:18.1, top 7 out of 140 in the field)
3. Fengwei Zhang , Wei Qiao , Ji-an Wei , Zhengyi Tao , Congjia Chen , Yefeng Wu , Minghui Lin , Ka Man Carmen Ng , Li Zhang , Kelvin Wai Kwok Yeung*, Billy Kwok Chong Chow*. Secretin-Dependent Signals in the Ventromedial Hypothalamus Regulate Energy Metabolism and Bone Homeostasis in Mice. Nature Communications, Vol.15, Article number: 1030, 3^rd February 2024. (IF:18.1, top 7 out of 140 in the field)
4. Yiming Xiang, Jiali Lu, Congyang Mao, Yizhou Zhu, Chaofeng Wang, Jun Wu, Xiangmei Liu*, Shuilin Wu*, Kenny Y. H. Kwan, Kenneth M. C. Cheung, Kelvin W. K. Yeung*. Ultrasound-triggered interfacial engineering-based microneedle for bacterial infection acne treatment. Science Advances, Vol. 9(10), pp.eadf0854, 8 March, 2023. (IF:13.9, top 11 out of 140 in the field)
5. Wei Qiao, Hui En Lau, Huizhi Xie, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Hin Chu, Shuofeng Yuan, Terrence Tsz-Tai Yuen, Kenn Ka-Heng Chik, Jessica Oi-Ling Tsang, Chris Chun-Yiu Chan, Jian-Piao Cai, Cuiting Luo, Kwok-Yong Yuen, Kenneth Man-Chee Cheung, Jasper Fuk-Woo Chan*, Kelvin Wai-Kwok Yeung*. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nature Communications, Vol.13, Article number: 2539, May 2022. (IF:18.1, top 7 out of 140 in the field)
6. Wei Qiao, Dayu Pan, Yufeng Zheng, Shuilin Wu, Xuanyong Liu, Zhuofan Chen, Mei Wan, Shiqin Feng, Kenneth M.C. Cheung, Kelvin W.K. Yeung*, Xu Cao*. Divalent Metal Cations Stimulate Skeleton Interoception for New Bone Formation in Mouse Injury Models, Nature Communications, Vol.13, Article number: 535, January, 2022. (IF:18.1, top 7 out of 140 in the field)
7. Wei Qiao, Karen H.M. Wong, Jie Shen, Wenhao Wang, Jun Wu, Jinhua Li, Zhengjie Lin, Zetao Chen, Jukka P. Matinlinna, Yufeng Zheng, Shuilin Wu, Xuanyong Liu, Keng Po Lai, Zhuofan Chen*, Yun Wah Lam*, Kenneth M.C. Cheung, Kelvin W.K. Yeung*. TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration. Nature Communications, Vol.12, Article number: 2885, May 2021.  (IF:18.1, top 7 out of 140 in the field)
8. Yizhou Zhu‚ Hang Liang, Xiangmei Liu*, Jun Wu, Cao Yang*, Tak Man Wong, Kenny Y. H. Kwan, Kenneth M. C. Cheung, Shuilin Wu, and Kelvin W. K. Yeung*. Regulation of macrophage polarization through surface topography design to facilitate implant-to-bone osteointegration. Science Advances, Vol. 7(14), pp.eabf6654, 2 April, 2021. (IF:13.9, top 11 out of 140 in the field)
9. Zhang,  M. Li,  S. Chen,  H. Du,  H. Zhong,  J. Wu,  F. Liu,  Q. Zhang,  F. Peng*,  X. Liu*,  Kelvin W.K. Yeung*.  Novel Palladium Hydride Surface Enabling Simultaneous Bacterial Killing and Osteogenic Formation through Proton Capturing and Activation of Antioxidant System in Immune Microenvironments. Advanced Materials, early online, pp. 2404485, 17^th May 2024. (IF:29.4, top 3 out of 230 in the field)
10. Congyang Mao, Wanyu Jin, Yiming Xiang, Yizhou Zhu, Jun Wu, Xiangmei Liu, Shuilin Wu, Yufeng Zheng, Kenneth M.C. Cheung, Kelvin Wai Kwok Yeung*. Realising highly efficient sonodynamic bactericidal capability through the phonon–electron coupling effect using two-dimensional catalytic planar defects. Advanced Materials, Vol.35(9), pp. 2208681, March 2023. (IF:29.4, top 3 out of 230 in the field)

(*These authors equally shared corresponding authorship and ^# shared the 1^st authorship)

[Updated on 28^th Aug 2026]